Home › NDC Lookup › Ingredients › Menthol And Methyl Salicylate › 41167-0600-03
🧴image loading
(from DailyMed)

Arthritis Hot Menthol and Methyl Salicylate 10 g/100g; 15 g/100g Cream — NDC 41167-0600-3 (Billing 41167-0600-03)

by Chattem, Inc. · 1 TUBE in 1 CARTON / 85 g in 1 TUBE

This is a package of Arthritis Hot Menthol and Methyl Salicylate 10 g/100g; 15 g/100g Cream from Chattem, Inc., marketed since Dec 1998 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 41167-0600-03
🏷️ FDA NDC (as labeled) 41167-0600-3 billing pads the package segment with a zero
This package
Contains85 g in 1 tube Pack sizes2 compare ↓
Main listing for product 41167-0600 · Also comes in: 85 g 41167-0600-4
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 41167-0600-3
Product NDC 41167-0600
11-digit billing NDC 41167060003
NCPDP billing unit GM — per gram (weight)
RxCUI 311498, 2105947
UNII L7T10EIP3A, LAV5U5022Y
Application # M017
SPL Set ID cc57b9b6-8ba5-4ff3-a5df-97d8f5b1bebd
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1998-12-01
Route TOPICAL
Dosage form CREAM
Substance MENTHOL; METHYL SALICYLATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 061801
GCN 97586
HICL code 002583
Ingredient (HICL) Methyl Salicylate/Menthol
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L6
Therapeutic class — intermediate (HIC2) Irritants
HIC3 code L6A
Therapeutic class — specific (HIC3) Irritants/Counter-Irritants
AHFS code 28:08.04.24
AHFS class Salicylates
FDB label name ARTHRITIS HOT 15%-10% CREAM
FDB brand name Arthritis Hot Pain Relief
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 061801
  • GCN: 97586
  • HICL (First Databank): 002583
  • AHFS class code: 28:08.04.24
  • RxCUI (RxNorm): 311498
Why two NDCs? The FDA registers this code as 41167-0600-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 41167-0600-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name ARTHRITIS HOT 15%-10% CREAM Ingredient Methyl Salicylate/Menthol
📗 Our plain-language guide HelloPharmacist
  • It is used on the skin for short-term relief of minor muscle and joint aches. That includes arthritis, backache, strains, sprains and bruises. Some products, like Diclofenac Sodium...
  • Apply it only to clean, intact skin, and follow your product's directions on how often. Wash your hands after using creams or handling patches, and keep it away from your eyes. Don...
  • A short burning feeling, redness or mild irritation where you apply it is the most common. It usually fades in several days. Stop and call your doctor if you get severe burning, bl...
  • Be careful. Methyl salicylate is a salicylate, related to aspirin, and labels say to talk to a doctor first if you are prone to allergic reactions to aspirin or salicylates. Some l...
📖 Read our full Menthol / Methyl Salicylate guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 85 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
41167-0600-03 You're viewing this Main listing 1 TUBE in 1 CARTON / 85 g in 1 TUBE 1998-12-01 — Active
41167-0600-04 41167-0600-4 1 TUBE in 1 CARTON / 85 g in 1 TUBE 2023-08-04 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 85 g in 1 tube.
What NDC number is used to bill for this package of Arthritis Hot Menthol and Methyl Salicylate 10 g/100g; 15 g/100g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Muscle Rub 100 mg/g; 150 mg/g 00536-1349-57 Rugby 1 tube $0.037 — Availability likely —
Dr Sheffield Muscle Rub Cream 100 mg/g; 150 mg/g 11527-0057-40 Sheffield 1 tube — — FDA listed —
Arthritis Hot 10 g/100g; 15 g/100gthis 41167-0600-03 Chattem, 1 tube — — FDA listed —
CVS Muscle Rub 150 mg/g; 100 mg/g 51316-0994-03 CVS 85 g — — FDA listed —
CAREALL Muscle Rub Ultra Strength 100 mg/g; 150 mg/g 51824-0007-03 New 85 g — — FDA listed —
CAREALL Muscle Rub Ultra Strength 100 mg/g; 150 mg/g 51824-0105-03 New 85 g — — FDA listed —
Analgesic Balm 10 g/100g; 15 g/100g 57896-0116-01 Geri-Care 1 tube — — FDA listed —
DynaRub 10 g/100g; 15 g/100g 67777-0113-50 Dynarex 72 tubes — — FDA listed —
Dr Sheffield Muscle Rub Cream 100 mg/g; 150 mg/g 68071-1624-05 NuCare 35 g — — FDA listed —
Rugby Muscle Rub Cream 100 mg/g; 150 mg/g 68071-3789-03 NuCare 1 tube — — FDA listed —
Muscle Rub Cream 10 g/100g; 15 g/100g 68788-8544-08 Preferred 1 tube — — FDA listed —
Rugby Muscle Rub Cream 100 mg/g; 150 mg/g 68788-8729-08 Preferred 1 tube — — FDA listed —
Muscle Rub Cream .1 g/100g; .15 g/100g 69396-0024-05 Trifecta 1 tube — — FDA listed —
Muscle Rub Cream 10 g/100g; 15 g/100g 69396-0110-30 Trifecta 1 tube — — FDA listed —
Pain Reliever Cream 10 g/100g; 15 g/100g 69396-0151-01 Trifecta 1 tube — — FDA listed —
TheraCare Muscle and Join Pain Relieving Cream 100 mg/g; 150 mg/g 71101-0012-01 Veridian 1 tube — — FDA listed —
AsperFlex 100 mg/g; 150 mg/g 71399-6854-03 Akron 85 g — — FDA listed —
Calypxo HP Pain Relief 15 g/100g; 10 g/100g 76420-0999-01 Asclemed 113 g — — FDA listed —
Muscle Rub 10 g/100g; 15 g/100g 87236-0005-01 Aldermed 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1998
On the market since
Dec 1998
📍
2026
Currently FDA-listed
28 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerChattem, Inc.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code41167
First marketedDec 1998
Product typeHuman Otc Drug
Portfolio157 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Uses temporarily relieves minor pain associated with: arthritis simple backache muscle strains sprains bruises cramps

Uses temporarily relieves minor pain associated with: arthritis simple backache muscle strains sprains bruises

⏱️ Dosage and Administration 118 words ▾

Directions adults and children over 12 years: ■ apply a thin layer to affected area ■ massage into painful area until thoroughly absorbed into skin ■ repeat as necessary, but no more than 3 to 4 times daily ■ IF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATER children 12 years or younger: ask a doctor

Directions adults and children over 12 years: ■ apply a thin layer to affected area ■ massage into painful area until thoroughly absorbed into skin ■ repeat as necessary, but no more than 3 to 4 times daily ■ IF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATER children 12 years or younger: ask a doctor

⚠️ Warnings ~2 min read ▾

Warnings For external use only Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use. When using this product ■ use only as directed. Read and follow all directions and warnings on this label. ■ rare cases of serious burns have been reported with products of this type ■ do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use ■ avoid contact with eyes and mucous membranes ■ do not apply to wounds or damaged, broken or irritated skin ■ a transient burning sensation may occur upon application but generally disappears in several days ■ if severe burning sensation occurs, discontinue use immediately ■ do not expose the area treated with product to heat or direct sunlight Stop use and ask a doctor if condition worsens redness is present Irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied If pregnant or breast-feeding, ask a health care professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Warnings For external use only Allergy alert: if prone to allergic reaction from aspirin or salicylates, consult a doctor before use. When using this product ■ use only as directed. Read and follow all directions and warnings on this label. ■ rare cases of serious burns have been reported with products of this type ■ do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use ■ avoid contact with eyes and mucous membranes ■ do not apply to wounds or damaged, broken or irritated skin ■ a transient burning sensation may occur upon application but generally disappears in several days ■ if severe burning sensation occurs, discontinue use immediately ■ do not expose the area treated with product to heat or direct sunlight Stop use and ask a doctor if condition worsens redness is present Irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 14 words ▾

Active ingredients Menthol 10% Methyl salicylate 15%

Active ingredients Menthol 10% Methyl salicylate 15%

🧪 Inactive Ingredients 37 words ▾

Inactive ingredients Carbomer, cetearyl alcohol, cetyl esters, diisapropyl adipate, oleth-3 phosphate, polysorbate 60, stearic acid, triethanolamine, water Arthritis Hot Cream

Inactive ingredients Carbomer, cetearyl alcohol, cetyl esters, diisapropyl adipate, oleth-3 phosphate, polysorbate 60, stearic acid, triethanolamine, water

🎯 Purpose 6 words ▾

Purpose Topical analgesic

Purpose Topical analgesic

📄 When Using This Product ~1 min read ▾

When using this product ■ use only as directed. Read and follow all directions and warnings on this label. ■ rare cases of serious burns have been reported with products of this type ■ do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use ■ avoid contact with eyes and mucous membranes ■ do not apply to wounds or damaged, broken or irritated skin ■ a transient burning sensation may occur upon application but generally disappears in several days ■ if severe burning sensation occurs, discontinue use immediately ■ do not expose the area treated with product to heat or direct sunlight

When using this product ■ use only as directed. Read and follow all directions and warnings on this label. ■ rare cases of serious burns have been reported with products of this type ■ do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use ■ avoid contact with eyes and mucous membranes ■ do not apply to wounds or damaged, broken or irritated skin ■ a transient burning sensation may occur upon application but generally disappears in several days ■ if severe burning sensation occurs, discontinue use immediately ■ do not expose the area treated with product to heat or direct sunlight

📄 Stop Use and Ask a Doctor If 96 words ▾

Stop use and ask a doctor if condition worsens redness is present Irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

Stop use and ask a doctor if condition worsens redness is present Irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

🤰 If Pregnant or Breast-Feeding 21 words ▾

If pregnant or breast-feeding, ask a health care professional before use.

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 38 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 62 words ▾

PRINCIPAL DISPLAY PANEL NDC 41167-0600-4 Arthritis Penetrating Pain Relief Cream NET WT 3 OZ (85g) PRINCIPAL DISPLAY PANEL NDC 41167-0600-4 Arthritis Penetrating Pain Relief Cream NET WT 3 OZ (85g)

PRINCIPAL DISPLAY PANEL NDC 41167-0600-3 Arthritis Deep Penetrating Pain Relief Crème NET WT 3 OZ (85g) PRINCIPAL DISPLAY PANEL NDC 41167-0600-3 Arthritis Deep Penetrating Pain Relief Crème NET WT 3 OZ (85g)

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Chattem, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (41167-0600-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Chattem, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 41167-0599-09 · Chattem, 41167-0608-00 · Chattem, →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.